DrugPatentWatch Database Preview
Litigation Details for Merck & Co. Inc. v. Apotex Inc. (D. Del. )
Email this page to a colleague
See Plans and PricingMerck & Co. Inc. v. Apotex Inc. (D. Del. )
| Docket | Start Trial | Date Filed | |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | |
| Jury Demand | Referred To | ||
| Patents | 5,358,941; 5,681,590; 5,849,726; 5,994,329; 6,008,207; 6,015,801; 6,090,410; 6,194,004; 6,225,294 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Merck & Co. Inc. v. Apotex Inc.
The small molecule drugs covered by the patents cited in this case are Start Trial , Start Trial , Start Trial , and Start Trial .
Details for Merck & Co. Inc. v. Apotex Inc. (D. Del. )
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2007-05-21 | 88 | The patents listed in Merck’s NDA, which are the patents-in~suit, are U.S. Patent Nos. 5,358,941; 5,681,590…required patent information relating to such patent has not been filed; (ii) that such patent has expired…may be sued for patent infringement If the NDA sponsor or patent owner files a patent infringement suit…information about patents for the drug product that is the subject of the NDA. The FDA publishes patent information…expired; (iii) that the patent will expire on a particular date; or (iv) that such patent is invalid or will | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
